A Study to Learn More About What Japanese Patients With Solid Tumors Think About Taking Medicine That is Based on Their Genetic Information

Inclusion Criteria: Part 1: * Adult female or male patient * Diagnosis of a solid tumor * Patients familiar with panel tests to be defined as: * Patients who have taken a panel test * Patients who have not taken a panel test * Patients who have tried or considered taking a panel test * Patients who have been offered a panel test but refused * Signed informed consent * Is 20 years of age or older Part 2 and Part 3 (patients): * Female or male patient * Diagnosis of a solid tumor (lung, or one of rare tumors defined by National Cancer Center and MHLW: mouth and lip, ovary and fallopian tube, urinary tract, soft tissue sarcoma, neuroendocrine, glioma, oropharynx, salivary, testis, parathesis, teratoma, skin melanoma, small intestine, nasal, nasal sinus, skin appendages, mesothelioma, GIST, vaginal and vulvar, thymic, nasopharynx, bone sarcoma, anus, uterine carcinosarcoma, penile, extragonadal germ cell, embryonal carcinoma, mucosa melanoma, pineal, brain and CNS, eye, peripheral nerve, trachea, melanoma of uvea, meningioma, histocytic and dendritic cell, trophoblastic tumor of placenta, Kaposi sarcoma, middle ear) * Sees the doctor for cancer treatment on regular basis (at least once every three months) * Signed informed consent * Is 20 years of age or older Part 2 and Part 3 (physician): * Has prescribed anti-cancer drugs to patients with a solid tumor (lung or one of rare tumors defined by National Cancer Center and MHLW: mouth and lip, ovary and fallopian tube, urinary tract, soft tissue sarcoma, neuroendocrine, glioma, oropharynx, salivary, testis, parathesis, teratoma, skin melanoma, small intestine, nasal, nasal sinus, skin appendages, mesothelioma, GIST, vaginal and vulvar, thymic, nasopharynx, bone sarcoma, anus, uterine carcinosarcoma, penile, extragonadal germ cell, embryonal carcinoma, mucosa melanoma, pineal, brain and CNS, eye, peripheral nerve, trachea, melanoma of uvea, meningioma, histocytic and dendritic cell, trophoblastic tumor of placenta, Kaposi sarcoma, middle ear) in the last 3 months. * Signed informed consent Exclusion Criteria: Part 1: * Non-Japanese speakers * Declaring to be too unwell to perform an interview Part2 and Part 3 (patients): * Non-Japanese speakers * Declaring to be too unwell to complete the survey * Participation in the pilot study Part 2 and Part 3 (physician): \- Non-Japanese speakers